An Overview of the Latest Treatments for Thyroid and Nasopharyngeal Cancers - On Demand

Wednesday, September 15, 2021, 7:00 PM - Thursday, September 15, 2022, 8:15 PM

Presented by Memorial Sloan Kettering’s (MSK) Physician Relations Team, An Overview of the Latest Treatments for Thyroid and Nasopharyngeal Cancers examines the occurrence rate of thyroid cancer along with approaches towards diagnosis and management of the disease. MSK physicians, Dr. Richard Wong and Dr. Nancy Lee, also discuss the current landscape of treatment for nasopharyngeal cancer, the role of proton therapy, and what the future of this disease may look like.

This on demand program is complimentary for all. Select the 'Course Content' tab above to view the previously recorded lecture. CME credit is offered for this on demand program and instructions can be found under course content.

This on demand program will be available until September 15, 2022.
Access to the videos and claiming credit will be available until September 15, 2022.

MSK’s Physician Relations Team is your direct connection to MSK physicians, information about the services offered in your area and assistance with the referral process to make it as seamless as possible for your patients. The Physician Relations Team will also keep you up to date on the numerous clinical trials MSK offers and inform you of our latest research and treatment advances. For further information about MSK's Physician Relations Team, please email [email protected].

1. Examine the occurrence rate of thyroid cancer
2. Review approaches towards diagnosing and management thyroid cancer
3. Assess the current landscape of treatment for nasopharyngeal cancer
4. Basic comprehension of proton therapy for nasopharyngeal cancer
5. Planning for the future of nasopharyngeal cancer

Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement

Memorial Sloan Kettering Cancer Center designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Recorded/Review Date: August 17, 2021; Original Release Date: September 15, 2021; Termination Date: September 15, 2022